Why Planet Fitness Stock Is a Better Investment Than Peloton Stock

Like so many other industries, gyms across the nation were shut down due to COVID-19. Companies offering at-home fitness solutions — like Peloton (NASDAQ:PTON) — should continue to thrive in this environment thanks to featuring products that enable both fitness and social distancing.

When thinking longer term, however, Planet Fitness (NYSE:PLNT) — a traditional brick-and-mortar gym chain — is the best way to invest in the space. Here’s why.

A woman working out.

Image source: Getty Images.

Better investment in a post-COVID world

Planet Fitness offers shareholders better value. The company trades hands at a trailing price to sales multiple of 8.9. Planet Fitness sales will shrink this year before rebounding in 2021. To compare, Peloton exchanges hands for a trailing price to sales multiple of 16.4. This is even after the stock pulled back 15% off of all-time highs this month. Planet Fitness’s forward earnings multiple of 34 also matches up favorably to

Read More

ICON Health & Fitness Announces $200 Million Growth Investment Led By L Catterton

Investment Will Further Accelerate Growth of Fitness Leader’s Connected Equipment and Industry-leading Subscription Technology Platform iFit

ICON Health & Fitness (“ICON”), the world leader in innovation, design and distribution of connected fitness equipment and software, today announced a $200 million growth investment led by L Catterton, the largest and most global consumer-focused private equity firm, and is joined by existing investor Pamplona Capital Management.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201005005720/en/

(Photo: Business Wire)

ICON owns established industry-leading fitness brands NordicTrack®, ProForm® and Freemotion®, which offer connected fitness membership services powered by iFit, the immersive live and on-demand streaming fitness and wellness media platform.

With revenue exceeding $1 billion in the last 12 months (ending September 30, 2020), ICON is the only company which creates connected fitness experiences across multiple brands, multiple product categories and all consumer fitness segments.

The investment will further accelerate ICON’s unique

Read More

What Can Healthcare Providers in the CEE region do to Attract More Healthcare Investment? Infiniti’s Experts Reveal Key Growth Drivers

The Central and Eastern Europe (CEE) healthcare sector must shift focus to creating a successful healthcare system and attracting more healthcare investments. How can healthcare providers in CEE attract more healthcare investments? According to Infiniti’s industry experts, providers must adopt advanced healthcare technologies, such as cancer screenings, electronic patient registries, improve patient mobility and accessibility to healthcare, and follow practices like outcome-based reimbursement. With Infiniti’s solutions, healthcare providers can better understand their market, how to efficiently capitalize on factors fueling growth, and create a successful system. To gain a comprehensive understanding of the CEE healthcare sector, and learn how companies can encourage more healthcare investments, request a free proposal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005606/en/

Three Key Factors Fueling Healthcare Investments in the CEE Region (Graphic: Business Wire)

Recently, reforming health services has become a priority on the political agenda, which has fueled growth in

Read More

Compass Pathways (NASDAQ:CMPS) IPO Proves Psychedelic Medicine Investment Thesis

WPSS Investments, a pioneer biotech Venture Capital fund focused on brain health and psychedelic medicine, celebrates the successful IPO of its portfolio company Compass Pathways. 

On September 18th, 2020 Compass Pathways was listed on NASDAQ (NASDAQ:CMPS), making it the first psychedelic company to be listed on a U.S. exchange. CMPS´s price per share has surged more than 100% since its initial listing price of 17USD, turning it into the most valuable and first unicorn psychedelic medicine company in the world.

Compass Pathways, was co-founded several years ago by George Goldsmith and Ekaterina Malievskaia who experienced the painful effects of depression within their own family.  Together Lars Christian Wilde they set out to develop psilocybin (the active compound in magic mushrooms) for use in patients with treatment-resistant depression. Compass Pathways is currently in phase II trials of the FDA which should bring in promising results in 2021.

WPSS invested in Compass

Read More